• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.

作者信息

Burns D E, Schiffman F J

机构信息

Department of Medicine, Miriam Hospital, Brown University, Providence, RI 02906.

出版信息

Chest. 1993 Dec;104(6):1916-9. doi: 10.1378/chest.104.6.1916.

DOI:10.1378/chest.104.6.1916
PMID:8252989
Abstract

An 18-year-old woman was diagnosed as having Hodgkin's disease involving the mediastinal lymph nodes and lung parenchyma. A pretreatment gallium 67 scan showed increased uptake in the mediastinum. Chest radiograph and chest computed tomographic (CT) scans after chemotherapy demonstrated resolution of disease, and a repeated gallium scan was normal. Four months later, a surveillance gallium scan showed increased activity in the mediastinal and hilar regions with corresponding chest CT and magnetic resonance imaging (MRI) showing a retrosternal mass. Prior to committing the patient to aggressive treatment for presumed disease relapse, a biopsy of the mass was performed and a specimen showed normal thymus tissue. The patient has continued in remission without further therapy 3 years after her initial treatment, with subsequent normal gallium scans and a stable mass on CT and MRI. Thymic enlargement following chemotherapy can occur with Hodgkin's disease in young adults, and interpretation of imaging studies, including gallium scanning, must be made with this consideration in mind.

摘要

相似文献

1
Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
Chest. 1993 Dec;104(6):1916-9. doi: 10.1378/chest.104.6.1916.
2
Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.用铊-201闪烁扫描术评估霍奇金病治疗后对镓-67摄取的纵隔肿块。
J Nucl Med. 1993 Aug;34(8):1326-30.
3
Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.镓-67扫描作为计算机断层扫描的辅助手段,用于评估霍奇金病小儿患者残留的纵隔肿块。一项儿科肿瘤学组研究。
Cancer. 1991 Dec 1;68(11):2478-80. doi: 10.1002/1097-0142(19911201)68:11<2478::aid-cncr2820681126>3.0.co;2-3.
4
High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma.高度恶性非霍奇金淋巴瘤患儿化疗结束后镓-67在纵隔良性摄取的高频率。
J Clin Oncol. 1989 Dec;7(12):1800-6. doi: 10.1200/JCO.1989.7.12.1800.
5
Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.用镓扫描进行再分期可识别对化疗敏感的患者,并预测预后不良的纵隔霍奇金病患者的生存情况。
Med Oncol. 2000 May;17(2):127-34. doi: 10.1007/BF02796208.
6
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.纵隔霍奇金病患者镓扫描、计算机断层扫描和磁共振成像的比较。
Ann Oncol. 1997;8 Suppl 1:53-6.
7
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.用镓-67、CT扫描和磁共振成像监测霍奇金病和高级别非霍奇金淋巴瘤的纵隔大肿块病变。
Leuk Lymphoma. 1996 Jun;22(1-2):131-5. doi: 10.3109/10428199609051740.
8
The value of thoracic computed tomography in the detection of recurrent Hodgkin's disease.胸部计算机断层扫描在复发性霍奇金病检测中的价值。
Br J Radiol. 1988 Jul;61(727):567-72. doi: 10.1259/0007-1285-61-727-567.
9
Gallium scanning in the management of mediastinal Hodgkin's disease.镓扫描在纵隔霍奇金病治疗中的应用
Eur J Haematol. 1989 Apr;42(4):344-7. doi: 10.1111/j.1600-0609.1989.tb01223.x.
10
Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.接受化疗的纵隔霍奇金病患者的镓扫描。
J Clin Oncol. 1993 Jun;11(6):1092-8. doi: 10.1200/JCO.1993.11.6.1092.